The Clinical Relevance of Force Platform Measures in Multiple Sclerosis: A Review

by Luca Prosperini, Carlo Pozzilli
Published 2013-01-01

Cost-effectiveness analysis of escalating to natalizumab or switching among immunomodulators in relapsing-remitting multiple sclerosis in Italy

by Gianluca Furneri, Laura Santoni, Chiara Ricella, Luca Prosperini
Published 2019-06-01

Functional and Structural Brain Plasticity Enhanced by Motor and Cognitive Rehabilitation in Multiple Sclerosis

by Luca Prosperini, Maria Cristina Piattella, Costanza Giannì, Patrizia Pantano
Published 2015-01-01

Oral Dalfampridine Improves Standing Balance Detected at Static Posturography in Multiple Sclerosis

by Luca Prosperini, Costanza Giannì, Deborah Fortuna, Maria Rita Marchetti, Carlo Pozzilli
Published 2014-01-01

Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis

by Luca Prosperini, Revere P. Kinkel, Augusto A. Miravalle, Pietro Iaffaldano, Simone Fantaccini
Published 2019-03-01

Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial

by Carlo Pozzilli, Luca Prosperini, Silvia Tommasin, Claudio Gasperini, Elena Barbuti, Laura De Giglio
Published 2021-04-01

Cost-Effectiveness Analysis of Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis: An Italian Societal Perspective

by Lorenzo Giovanni Mantovani, Gianluca Furneri, Rossella Bitonti, Paolo Cortesi, Elisa Puma, Laura Santoni, Luca Prosperini
Published 2019-07-01

Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.

by Emilia Sbardella, Nikolaos Petsas, Francesca Tona, Luca Prosperini, Eytan Raz, Gianvito Pace, Carlo Pozzilli, Patrizia Pantano
Published 2013-01-01

The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma

by Veronica Villani, Beatrice Casini, Andrea Pace, Luca Prosperini, Carmine M. Carapella, Antonello Vidiri, Alessandra Fabi, Mariantonia Carosi
Published 2015-01-01

Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry.

by Luca Prosperini, Nicola de Rossi, Cristina Scarpazza, Lucia Moiola, Mirco Cosottini, Simonetta Gerevini, Ruggero Capra, Italian PML study group
Published 2016-01-01

Bell’s Palsy: Symptoms Preceding and Accompanying the Facial Paresis

by Daniele De Seta, Patrizia Mancini, Antonio Minni, Luca Prosperini, Elio De Seta, Giuseppe Attanasio, Edoardo Covelli, Andrea De Carlo, Roberto Filipo
Published 2014-01-01

A Comprehensive Approach to Disentangle the Effect of Cerebellar Damage on Physical Disability in Multiple Sclerosis

by Serena Ruggieri, Serena Ruggieri, Komal Bharti, Luca Prosperini, Costanza Giannì, Nikolaos Petsas, Silvia Tommasin, Laura De Giglio, Carlo Pozzilli, Patrizia Pantano, Patrizia Pantano
Published 2020-06-01

The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).

by Alessandro Enrico Grimaldi, Laura De Giglio, Shalom Haggiag, Assunta Bianco, Antonio Cortese, Sebastiano Giuseppe Crisafulli, Fabrizia Monteleone, Gerola Marfia, Luca Prosperini, Simonetta Galgani, Massimiliano Mirabella, Diego Centonze, Carlo Pozzilli, Letizia Castelli
Published 2019-01-01

The Use of Social Media and Digital Devices Among Italian Neurologists

by Luigi Lavorgna, Francesco Brigo, Francesco Brigo, Gianmarco Abbadessa, Sebastiano Bucello, Marinella Clerico, Eleonora Cocco, Rosa Iodice, Roberta Lanzillo, Letizia Leocani, Letizia Leocani, Alberto Lerario, Marcello Moccia, Marcello Moccia, Alessandro Padovani, Luca Prosperini, Anna Repice, Maria Stromillo, Francesca Trojsi, Gianluigi Mancardi, Gioacchino Tedeschi, Simona Bonavita
Published 2020-06-01